TOKYO, Mar 5, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that the latest data from its Alzheimer’s disease (AD) and dementia pipeline, including the investigational anti-amyloid beta (Aß) protofibril antibody lecanemab (Development Code: BAN2 […]

TOKYO, Mar 3, 2021 – (JCN Newswire via SEAPRWire.com) – Hitachi, Ltd. has announced that it has developed the Hitachi Electronic Signature Service, which implements secure electronic contracts based on blockchain (distributed ledger) technology. The Service digitizes the signatures and s […]